2K2D

Solution NMR structure of C-terminal domain of human pirh2. Northeast Structural Genomics Consortium (NESG) target HT2C

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCO	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298
2	3D HNCA	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298
3	3D CBCA(CO)NH	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298
4	3D HBHA(CO)NH	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298
5	3D H(CCO)NH	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298
6	3D C(CO)NH	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298
7	3D HCCH-TOCSY	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	100% D2O	150	7	ambient	298
8	3D HCCH-TOCSY	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	100% D2O	150	7	ambient	298
9	3D 1H-15N NOESY	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298
10	3D 1H-13C NOESY	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298
11	3D 1H-13C-Aromatic NOESY	1 mM [U-99% 13C; U-99% 15N] C-terminal domain of human pirh2, 50 mM sodium phosphate, 150 mM potassium chloride, 10 uM ZnCl2, 0.8 mM DTT	90% H2O/10% D2O	150	7	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	AVANCE	600
3	Bruker	AVANCE	800
4	Varian	INOVA	500

NMR Refinement
Method	Details	Software
molecular dynamics		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe	2.3	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	peak picking	Sparky		Goddard
3	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
4	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
5	validation	AutoStructure		Huang, Tejero, Powers and Montelione
6	data analysis	TALOS		Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.